-
-
Peptide Name
- hACE2(21-55)A36K-F40E
-
Sequence
- IEEQAKTFLDKFNHEⓀEDLⒺYQSSLASWNYNTNIT
-
-
Original Sequence
- IEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNIT
-
Source
- Synthetic construct
-
-
Biological Activity
- Antimicrobial, Antiviral(SARS-CoV-2)
-
- Mechanism of action:The stapled peptide inhibit the RBD-hACE2 complex formation, and hACE2 α1-helix-based peptidomimetics could potentially prevent SARS-CoV-2 from entering the human cells through hACE2 and thus inhibit subsequent viral replication.
-
Target Organism
-
- [Ref.33651072]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 Spike protein-hACE2 complex formation(IC50=3.6 μM).
-
Hemolytic Activity
-
- No hemolytic activity information found.
-
Cytotoxicity
-
No cytotoxicity information found in the reference(s) presented
-
Linear/Cyclic
- Cyclic (Stapled)
-
N-terminal Modification
- Free
-
C-terminal Modification
- Free
-
Special Amino Acid and Stapling Position
- Ⓚ (16) and Ⓔ (20) are corss-linked by lactam stapling.
-
-
Secondary Structure
- ①52% α-helical content in 10 mM PBS at pH 7.4 with 30% TFE at 298 K.②6-13% α-helical content in 10 mM PBS at pH 7.4 and 298 K.
-
Structure Description
- Low helicity for stapled hACE2 peptides in absence of TFE, with predictors of helicity averaging to 6-13% helical content. In the presence of TFE, α-helical structures can be observed for various synthetic hACE2 peptides with predictors averaging from 11 to 52% helical content
-
-
There is no predicted structure for DRAMP29239.
- Literature 1
-
Title
- Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.
-
-
Reference
- Chem Commun (Camb). 2021 Apr 4;57(26):3283-3286.
-
Author
- Maas MN , Hintzen JCJ , Löffler PMG , Mecinović J .